Practice Area: Class Action
Outcome: $82 million settlement
Description: Defendant McKesson was alleged to have fraudulently inflated certain prescription drugs’ “Average Wholesale Price” or “AWP,” a benchmark that was widely used to determine the reimbursement price for many prescription medications. The court certified a nationwide class of local government entities that allegedly overpaid for prescription drugs as a result of overcharges by McKesson.